EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›KWR

KWR

QUAKER CHEMICAL CORP

Next earnings Jul 29, 2026 · consensus $1.63 EPS, $513M rev

Last earnings +2.0% on 2026-04-30

Sell
$160.63
▲ +2.58%
$160.63▲ +42.45%
over 1Y
L $110.26EODHDH $179.86
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+2.6%
1W+6.9%
1M+9.1%
3M+29.3%
YTD+16.4%
1Y+42.4%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Sell
Quality
C-
Valuation
Fair value
Filings
Watch
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 10 analysts
Buy

Unprofitable (net margin -0.1%).

Revenue (FY2025) $1.89B · FY2025

QUAKER CHEMICAL CORP shows $1.89B in FY2025 revenue (+2.7% YoY), a -0.1% net margin, and -0.2% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$1.76B$1.94B$1.95B$1.84B$1.89B
Gross profit$595M$613M$706M$686M$679M
Operating income$150M$52.3M$214M$195M$53.0M
Net income$121M-$15.9M$113M$117M-$2.49M
Diluted EPS$6.77-$0.89$6.26$6.51-$0.14
Net margin6.9%-0.8%5.8%6.3%-0.1%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$3.48B
EV / EBITDA29.3
EV / Sales1.8
EV / FCF43.1
P / FCF34.5
PEG (trailing)—
Earnings yield-0.1%
FCF yield2.9%

Quality & risk

ROIC (est.)1.9%
Free cash flow$80.6M
Total debt$871M
Net cash-$691M
Altman Z-Score2.44 grey
Piotroski F-Score4/9

Capital returns

Buyback yield1.5%
Dividend yield (est.)1.2%
Shareholder yield2.7%
Shares Δ YoY-1.9%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Officer / director change2026-05-15
  2. 8-K Earnings results2026-04-30
  3. 10-Q Quarterly report2026-04-30
  4. 8-K Material agreement2026-04-14
  5. DEF 14A Proxy statement2026-03-31
  6. 8-K Officer / director change2026-03-12
  7. 8-K Earnings results2026-02-23
  8. 10-K Annual report2026-02-23
  9. 8-K Earnings results2025-10-30

Recent filings

all on EDGAR ↗
4Period ending 2026-06-152026-06-17open ↗11-KPeriod ending 2025-12-312026-06-12open ↗4Period ending 2026-06-012026-06-03open ↗4Period ending 2026-05-312026-06-02open ↗4Period ending 2026-05-312026-06-02open ↗4Period ending 2026-05-312026-06-02open ↗4Period ending 2026-05-312026-06-02open ↗4Period ending 2026-05-312026-06-02open ↗4Period ending 2026-05-312026-06-02open ↗4Period ending 2026-05-312026-06-02open ↗4Period ending 2026-05-312026-06-02open ↗4Period ending 2026-05-312026-06-02open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
ValueA-
GrowthF
ProfitabilityF
Financial healthC+
Momentum—
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$1.89B
+2.7% YoY
Net margin
-0.1%
ROE
-0.2%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$1.89B+2.7%
Net income-$2.49M-102.1%
Gross profit$679M-1.0%
Operating income$53.0M-72.8%
Diluted EPS-$0.14-102.2%
Cash & equivalents$180M-4.8%
Total assets$2.80B+7.2%
Total liabilities$1.42B+13.1%
Stockholders' equity$1.37B+1.4%
Gross: 36.0%Op.: 2.8%L/E: 1.04x

Frequently asked

Is QUAKER CHEMICAL CORP (KWR) a buy?
KWR currently carries a Sell rating with 3/5 conviction, derived from its latest SEC filings. Unprofitable (net margin -0.1%).
What is QUAKER CHEMICAL CORP's quality score?
KWR scores 51.50980392156862/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000081362, latest 10-Q filed 2026-04-30) · EODHD · as of 6/26/2026, 1:04:46 AM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-06-15
Coler Thomas
EVP, CFO
Exercise2.35K
2026-06-15
Coler Thomas
EVP, CFO
Exercise68.00
2026-06-15
Coler Thomas
EVP, CFO
Tax741.00 @ $144.46$107K
2026-06-01
Foufopoulos - De Ridder Lucrece
Director
Award413.00 @ $145.24$60.0K
2026-06-01
Foufopoulos - De Ridder Lucrece
Director
Tax124.00 @ $145.24$18.0K
2026-06-01
DOUGLAS MARK
Director
Award766.00
2026-06-01
Shaller Russell
Director
Award413.00 @ $145.24$60.0K
2026-05-31
Foufopoulos - De Ridder Lucrece
Director
Exercise1.20K
2026-05-31
Foufopoulos - De Ridder Lucrece
Director
Exercise18.00
2026-05-31
Foufopoulos - De Ridder Lucrece
Director
Tax365.00 @ $143.53$52.4K
2026-05-31
DOUGLAS MARK
Director
Exercise1.20K
2026-05-31
DOUGLAS MARK
Director
Exercise18.00

Dividends

Quarterly
Yield (TTM)
1.6%
Annual / share
$2.52
Last ex-date
2026-07-17
Last amount
$0.51
ex 2026-07-17paid 2026-07-31$0.51
ex 2026-04-16paid 2026-04-30$0.51
ex 2026-01-16paid 2026-01-30$0.51
ex 2025-10-17paid 2025-10-31$0.51
ex 2025-07-17paid 2025-07-31$0.49
ex 2025-04-16paid 2025-04-30$0.49

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-04-30Miss -1.2% est▲ +1.98%8-K ↗
2026-02-23Miss -7.7% est▼ -2.56%8-K ↗
2025-10-30Beat +2.1% est▼ -3.63%8-K ↗
2025-07-31Miss -7.6% est▼ -0.25%8-K ↗
2025-05-01—▲ +0.07%8-K ↗
2025-02-24—▼ -0.66%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
KWR Enhances China Operations With New Facility at ZhangjiagangBullish
finance.yahoo.com· 2026-06-26
Quaker Houghton Opens New Manufacturing Site and Expanded Lab in ChinaBullish
finance.yahoo.com· 2026-06-25
Perimeter Solutions, SA (PRM) Surges 6.0%: Is This an Indication of Further Gains?Bullish
finance.yahoo.com· 2026-06-19
Perimeter Solutions, SA (PRM) Surges 6.0%: Is This an Indication of Further Gains?Bullish
nasdaq.com· 2026-06-19
International Flavors (IFF) Down 11.3% Since Last Earnings Report: Can It Rebound?Bullish
finance.yahoo.com· 2026-06-04
How The Story For Quaker Chemical (KWR) Is Evolving As Analyst Targets Hold SteadyBullish
finance.yahoo.com· 2026-06-04

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score52 vs 67
Revenue growth2.7% vs 7.1%
Net margin-0.1% vs 10.5%
Return on equity-0.2% vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 12d
Bullish
+0.08
vs typical · 18 articles
↓ cooling

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.